BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Diferuloylmethane {Curcumin} - Escherichia coli H30 |
👶
Nano-Microemulsions of CaCO(3)-Encapsulated Curcumin Ester Derivatives With High Antioxidant and Antimicrobial Activities and pH Sensitivity. Frontiers in veterinary science (Front Vet Sci ) Vol: 9 Issue Pages: 857064 Pub: 2022 Epub: 2022 Aug 11 Authors Wang L , Wang X , Guo Z , Xia Y , Geng M , Liu D , Zhang Z , Yang Y , Html Article Publication |
| Diferuloylmethane {Curcumin} - Escherichia coli H30 |
👶
Does Curcumin Have a Role in the Interaction between Gut Microbiota and Schistosoma mansoni in Mice? Pathogens (Basel, Switzerland) (Pathogens ) Vol: 9 Issue 9 Pages: Pub: 2020 Sep 19 Epub: 2020 Sep 19 Authors Anter A , El-Ghany MA , Abou El Dahab M , Mahana N , Html Article Publication |
| Diferuloylmethane {Curcumin} - Escherichia coli H30 |
👶
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 13 Issue 7 Pages: Pub: 2020 Jul 16 Epub: 2020 Jul 16 Authors Adamczak A , Ozarowski M , Karpinski TM , Html Article Publication |
| Diferuloylmethane {Curcumin} - Escherichia coli H30 |
👶
Investigating antibacterial and anti-inflammatory properties of synthetic curcuminoids. Frontiers in medicine (Front Med (Lausanne) ) Vol: 11 Issue Pages: 1478122 Pub: 2024 Epub: 2024 Oct 29 Authors Veselá K , Kejík Z , Abramenko N , Kaplánek R , Jakubek M , Petrlova J , Html Article Publication |
| Diferuloylmethane {Curcumin} - Escherichia coli H30 |
👶
Curcumin-sulfobutyl-ether beta cyclodextrin inclusion complex: preparation, spectral characterization, molecular modeling, and antimicrobial activity. Journal of biomolecular structure & dynamics (J Biomol Struct Dyn ) Vol: 42 Issue 19 Pages: 9977-9992 Pub: 2024 Epub: 2023 Sep 11 Authors Sravani AB , Shenoy K M , Chandrika B , Kumar B H , Kini SG , Pai K SR , Lewis SA , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
